Advancing Diagnosis and Individualized Treatment of Severe Asthma Through Application of Guidelines an Evaluation (ID: i761a)

Question Title

* 1. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

If not committed or do not plan to make changes, please indicate

Question Title

* 2. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

Question Title

* 3. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Knowledge of current recommendations for the diagnosis of severe asthma versus difficult-to-treat asthma versus uncontrolled persistent asthma

Knowledge of appropriate biomarker tests for determining the phenotype of patients with severe asthma

Knowledge of the mechanisms of action of approved targeted T2 biologic therapies for the treatment of severe asthma

An understanding of how to tailor treatment plans based upon the individual profiles of patients with severe asthma

An understanding of factors that predict a good response to add-on T2 biologic therapies for the treatment of severe asthma

An understanding of the risk of serious adverse effects associated with the long-term and short-term use of OCS in patients with severe asthma

Question Title

* 4. What barriers do you see to making changes in your practice?

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please specify)

Question Title

* 5. After participating in today’s activity, I am now better able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Demonstrate the ability to diagnose patients with severe versus difficult-to-treat versus persistent uncontrolled asthma	Demonstrate the ability to diagnose patients with severe versus difficult-to-treat versus persistent uncontrolled asthma Strongly agree	Demonstrate the ability to diagnose patients with severe versus difficult-to-treat versus persistent uncontrolled asthma Agree	Demonstrate the ability to diagnose patients with severe versus difficult-to-treat versus persistent uncontrolled asthma Neutral	Demonstrate the ability to diagnose patients with severe versus difficult-to-treat versus persistent uncontrolled asthma Disagree	Demonstrate the ability to diagnose patients with severe versus difficult-to-treat versus persistent uncontrolled asthma Strongly disagree
Describe the risks of OCS overuse and summarize strategies to reduce OCS use in severe asthma	Describe the risks of OCS overuse and summarize strategies to reduce OCS use in severe asthma Strongly agree	Describe the risks of OCS overuse and summarize strategies to reduce OCS use in severe asthma Agree	Describe the risks of OCS overuse and summarize strategies to reduce OCS use in severe asthma Neutral	Describe the risks of OCS overuse and summarize strategies to reduce OCS use in severe asthma Disagree	Describe the risks of OCS overuse and summarize strategies to reduce OCS use in severe asthma Strongly disagree
Employ biomarker testing in the evaluation of severe asthma and utilize results to classify patients with severe asthma	Employ biomarker testing in the evaluation of severe asthma and utilize results to classify patients with severe asthma Strongly agree	Employ biomarker testing in the evaluation of severe asthma and utilize results to classify patients with severe asthma Agree	Employ biomarker testing in the evaluation of severe asthma and utilize results to classify patients with severe asthma Neutral	Employ biomarker testing in the evaluation of severe asthma and utilize results to classify patients with severe asthma Disagree	Employ biomarker testing in the evaluation of severe asthma and utilize results to classify patients with severe asthma Strongly disagree
Develop personalized treatment plans for patients with severe asthma that are consistent with current evidence-based recommendations	Develop personalized treatment plans for patients with severe asthma that are consistent with current evidence-based recommendations Strongly agree	Develop personalized treatment plans for patients with severe asthma that are consistent with current evidence-based recommendations Agree	Develop personalized treatment plans for patients with severe asthma that are consistent with current evidence-based recommendations Neutral	Develop personalized treatment plans for patients with severe asthma that are consistent with current evidence-based recommendations Disagree	Develop personalized treatment plans for patients with severe asthma that are consistent with current evidence-based recommendations Strongly disagree

Question Title

* 6. Reynold A. Panettieri, Jr., M.D, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias	Avoided commercial bias Strongly agree	Avoided commercial bias Agree	Avoided commercial bias Neutral	Avoided commercial bias Disagree	Avoided commercial bias Strongly disagree

Question Title

* 7. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 8. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 9. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities on severe asthma or a related disease state:

Question Title

* 1. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 2. Which of the following best describes the impact of this activity on your performance?

Question Title

* 3. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 4. What barriers do you see to making changes in your practice?

Question Title

* 5. After participating in today’s activity, I am now better able to:

Question Title

* 6. Reynold A. Panettieri, Jr., M.D, effectively:

Question Title

* 7. The content presented:

Question Title

* 8. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 9. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities on severe asthma or a related disease state:

Question Title

* 10. If you indicated that you perceived commercial bias or influence, please describe: